Mogroside biocatalysis methods and products

US12247238B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12247238-B2
Application numberUS-202017434234-A
CountryUS
Kind codeB2
Filing dateFeb 26, 2020
Priority dateFeb 26, 2019
Publication dateMar 11, 2025
Grant dateMar 11, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Monk fruit extracts containing mogrol glycosides such as mogroside V may be treated with enzymes under specific reaction conditions to shift distribution of the Siamenoside I reaction product. Modified enzymes are also employed to shift Siamenoside I distribution to increase yield of Siamenoside I and reduce reaction contaminants. Methods of purifying bioconversion reaction product are also described. Siamenoside I obtained using these methods is a useful sweetener and flavor enhancer for food and beverage compositions and the like.

First claim

Opening claim text (preview).

The invention claimed is: 1. A modified beta-galactosidase enzyme comprising one or more mutations in the amino acid residues 200 through 212, wherein the beta-galactosidase enzyme having at least 50% identity to Aspergillus oryzae beta-galactosidase comprises one or more mutations selected from G204G, C205R, V208E or combinations thereof. 2. The modified beta-galactosidase enzyme of claim 1 , wherein the beta-galactosidase enzyme having at least 50% identity to Aspergillus oryzae beta-galactosidase comprises the mutations G204G, C205R and V208 E. 3. A modified beta-galactosidase enzyme comprising one or more mutations in the amino acid residues 200 through 212, wherein the beta-galactosidase enzyme having at least 50% identity to Aspergillus oryzae beta-galactosidase comprises one or more mutations in the loop region are selected from E142A, G204G, C205R, and V208E. 4. The modified beta-galactosidase enzyme of claim 3 , wherein the beta-galactosidase enzyme having at least 50% identity to Aspergillus oryzae beta-galactosidase comprises the mutations E142A, G204G, C205R and V208. 5. A method for purifying Siamenoside I from a reaction mixture comprising: a) providing a mixture of low purity mogrosides and reaction mixture reagents; b) separating the mogrosides from the reaction mixture reagents by (i) adjusting the pH of the mixture of a) to about 10 or higher, (ii) adding alcohol to provide an alcoholic solution and (iii) filtering the alcoholic solution through a first ultrafiltration membrane to provide a first filtered solution; c) adjusting pH of the first filtered solution to between about 5 and about 7 and filtering the through a second ultrafiltration membrane to provide a second filtered solution; d) performing diafiltration on the second filtered solution to concentrate the mogrosides, providing a mogroside mixture, then mixing the mogroside mixture with water/ammonia acetate to provide a mogroside/ammonium acetate solution; e) contacting the mogroside/ammonia acetate solution with a fractionation column; f) eluting and collecting fractions containing Siamenoside I; and g) drying the fractions containing Siamenoside I to obtain high purity Siamenoside I with a Siamenoside content of more than about 60% (w/w). 6. The method of claim 5 , wherein the mogroside mixture of step a) comprises at least 90% Mogroside V. 7. The method of claim 5 , wherein the mogroside mixture of step a) comprises at least 95% Mogroside V.

Assignees

Inventors

Classifications

  • Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase · CPC title

  • C07J17/005Primary

    Glycosides · CPC title

  • C12P33/00Primary

    Preparation of steroids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12247238B2 cover?
Monk fruit extracts containing mogrol glycosides such as mogroside V may be treated with enzymes under specific reaction conditions to shift distribution of the Siamenoside I reaction product. Modified enzymes are also employed to shift Siamenoside I distribution to increase yield of Siamenoside I and reduce reaction contaminants. Methods of purifying bioconversion reaction product are also des…
Who is the assignee on this patent?
Coca Cola Co
What technology area does this patent fall under?
Primary CPC classification C07J17/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).